| 000 | 01670 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516070758.0 | ||
| 264 | 0 | _c20121119 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-011-1908-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlackburn, Edith | |
| 245 | 0 | 0 |
_aA monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cJul 2012 |
||
| 300 |
_a53-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuregulin-1 _xmetabolism |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aReceptor, ErbB-3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aZona, Stefania | |
| 700 | 1 | _aMurphy, Mariana L | |
| 700 | 1 | _aBrown, Ian R | |
| 700 | 1 | _aChan, Samuel K W | |
| 700 | 1 | _aGullick, William J | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 134 _gno. 1 _gp. 53-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-011-1908-1 _zAvailable from publisher's website |
| 999 |
_c21392134 _d21392134 |
||